InVivo Biosystems Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 62

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3M

  • Investors
  • 16

InVivo Biosystems General Information

Description

Developer of a genome editing platform designed to accelerate deep in-vivo insights into human biology. The company's platform creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental and disease studies, enabling researchers to perform mutant phenotyping, drug screening and toxicological assessment.

Contact Information

Formerly Known As
NemaMetrics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 1505 Westec Drive
  • Eugene, OR 97402
  • United States
+1 (844) 000-0000

InVivo Biosystems Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InVivo Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 03-Jan-2024 $3M 000.00 Completed Generating Revenue
10. Later Stage VC 01-Apr-2023 00.00 Completed Generating Revenue
9. Grant 10-Dec-2020 00000 00.00 Completed Generating Revenue
8. Grant 24-Apr-2020 00000 00.00 Completed Generating Revenue
7. Debt - PPP 15-Apr-2020 00.00 Completed Generating Revenue
6. Later Stage VC 27-Feb-2019 00.000 00.00 Completed Generating Revenue
5. Later Stage VC (Series A) 08-Mar-2017 00.000 00.000 00.000 Completed Generating Revenue
4. Angel (individual) 28-Aug-2015 000.00 000.00 Completed Startup
3. Accelerator/Incubator 04-Feb-2015 Completed Startup
2. Grant 01-Feb-2014 $346K Completed Startup
To view InVivo Biosystems’s complete valuation and funding history, request access »

InVivo Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00.00 00.00
To view InVivo Biosystems’s complete cap table history, request access »

InVivo Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genome editing platform designed to accelerate deep in-vivo insights into human biology. The company's pl
Biotechnology
Eugene, OR
62 As of 2023
000.00
0000000000 0 000.00

000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
0000000000000
San Diego, CA
000 As of 0000
00.00 0000-00-00
000000&0

000000

um dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
0000 000000000
Shirley, NY
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InVivo Biosystems Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioLegend Corporate Backed or Acquired San Diego, CA 000 000000&0
Creative Biolabs Corporation Shirley, NY
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom 0000 000000000
Hera BioLabs Venture Capital-Backed Lexington, KY 00 00.000 00000000000 00.000
HistoCyte Laboratories Corporate Backed or Acquired Newcastle upon Tyne, United Kingdom 00 000000&0
You’re viewing 5 of 16 competitors. Get the full list »

InVivo Biosystems Patents

InVivo Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3162691-A1 Model organisms humanized for drug discovery and screening Pending 21-Dec-2019 00000000000
EP-4078179-A1 Model organisms humanized for drug discovery and screening Pending 21-Dec-2019 00000000000
US-20230200362-A1 Model organisms humanized for drug discovery and screening Pending 21-Dec-2019 00000000000
US-20220375609-A1 Clinical variant classifier models, machine learning systems and methods of use Pending 16-Oct-2019 000000000
CA-3131145-A1 Monogenic or polygenic disease model organisms humanized with two or more genes Pending 21-Feb-2019 A01K67/0336
To view InVivo Biosystems’s complete patent history, request access »

InVivo Biosystems Executive Team (11)

Name Title Board Seat Contact Info
Matt Beaudet Co-Founder, Chief Executive Officer & Board Member
Shawn Lockery Co-Founder, Chief Technology Officer & Board Member
Christopher Hopkins Chief Scientific Officer & Board Member
Anthony Iverson Vice President of Finance & Director of Finance and Accounting
Shulamit Jaron Ph.D Director of Business Development
You’re viewing 5 of 11 executive team members. Get the full list »

InVivo Biosystems Board Members (10)

Name Representing Role Since
Amy Tykeson Self Board Member 000 0000
Ann Bunnenberg InVivo Biosystems Board Member 000 0000
Chockalingam Palaniappan Ph.D InVivo Biosystems Chairman 000 0000
Chris Carlson Self Board Member 000 0000
Christopher Hopkins InVivo Biosystems Chief Scientific Officer & Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

InVivo Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InVivo Biosystems Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ideaship Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
The National Human Genome Research Institute Government 000 0000 000000 0
Oregon Nano and Micro technology Institute (ONAMI) Corporation Minority 000 0000 000000 0
Oregon Venture Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

InVivo Biosystems Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Knudra Transgenics 14-Nov-2017 0000000000 Biotechnology 0000 0000
To view InVivo Biosystems’s complete acquisitions history, request access »

InVivo Biosystems FAQs

  • When was InVivo Biosystems founded?

    InVivo Biosystems was founded in 2010.

  • Who is the founder of InVivo Biosystems?

    Matt Beaudet, Shawn Lockery, and Janis Weeks Ph.D are the founders of InVivo Biosystems.

  • Who is the CEO of InVivo Biosystems?

    Matt Beaudet is the CEO of InVivo Biosystems.

  • Where is InVivo Biosystems headquartered?

    InVivo Biosystems is headquartered in Eugene, OR.

  • What is the size of InVivo Biosystems?

    InVivo Biosystems has 62 total employees.

  • What industry is InVivo Biosystems in?

    InVivo Biosystems’s primary industry is Biotechnology.

  • Is InVivo Biosystems a private or public company?

    InVivo Biosystems is a Private company.

  • What is InVivo Biosystems’s current revenue?

    The current revenue for InVivo Biosystems is 000000.

  • How much funding has InVivo Biosystems raised over time?

    InVivo Biosystems has raised $12.2M.

  • Who are InVivo Biosystems’s investors?

    Ideaship, National Institutes of Health, The National Human Genome Research Institute, Oregon Nano and Micro technology Institute (ONAMI), and Oregon Venture Fund are 5 of 16 investors who have invested in InVivo Biosystems.

  • Who are InVivo Biosystems’s competitors?

    BioLegend, Creative Biolabs, Sygnature Discovery, Hera BioLabs, and HistoCyte Laboratories are some of the 16 competitors of InVivo Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »